Alyeska Investment Group
SION

Alyeska Investment Group’s Sionna Therapeutics SION Stock Holding History

Alyeska Investment Group’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.46M Hold
136,222
– – 0.02% 465
2025
Q4 		$5.6M Sell
136,222
-50,000
-27% -$1.9M 0.02% 446
2025
Q3 		$5.48M Hold
186,222
– – 0.02% 447
2025
Q2 		$3.23M Hold
186,222
– – 0.01% 458
2025
Q1 		$1.95M Buy
+186,222
New +$3.04M 0.01% 415

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group's SION Position: Q1 2026 in Review

Alyeska Investment Group held its Sionna Therapeutics (SION) position steady in Q1 2026 at 136,222 shares worth $5.46M. The position accounts for 0.02% of the portfolio, ranked #465.

Alyeska Investment Group first reported a position in SION in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.6M in Q4 2025. 122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

  • Alyeska Investment Group held 136,222 shares of Sionna Therapeutics worth $5.46M as of Q1 2026.
  • Alyeska Investment Group left its Sionna Therapeutics share count unchanged in Q1 2026.
  • Sionna Therapeutics made up 0.02% of Alyeska Investment Group's portfolio in Q1 2026, its #465 holding.
  • Alyeska Investment Group first reported a position in Sionna Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Alyeska Investment Group's Sionna Therapeutics position peaked at $5.6M in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.